The Genome Empowerment Scale (GEmS): An Assessment of Parental Empowerment in Families with Undiagnosed Disease. McConkie-Rosell Allyn et al. Clinical genetics 2019 Aug

Main|Search|PHGKB




Last Posted: Aug 28, 2019

---

• The Genome Empowerment Scale (GEmS): An Assessment of Parental Empowerment in Families with Undiagnosed Disease.
  McConkie-Rosell Allyn et al. Clinical genetics 2019 Aug
• Can Machine Learning help us in dealing with treatment resistant depression? A review.
  Pigoni Alessandro et al. Journal of affective disorders 2019 Aug 25921-26
• Using Electronic Health Records and Machine Learning to Predict Postpartum Depression.
  Wang Shuojia et al. Studies in health technology and informatics 2019 Aug 264888-892
• Digital Phenotyping With Mobile and Wearable Devices: Advanced Symptom Measurement in Child and Adolescent Depression.
  Sequeira Lydia et al. Journal of the American Academy of Child and Adolescent Psychiatry 2019 Sep 58(9) 841-845
• Pharmacogenomic considerations for medications in the perioperative setting.
  Jhun Ellie H et al. Pharmacogenomics 2019 Jul 20(11) 813-827
• Robin Williams' Son Zak Says He Struggled with Depression: 'I Found Myself Self-Medicating'
  H Murphy, People, August 20, 2019
• Examining the Importance of Family History in Pediatric Behavioural Referrals.
  Gander Sarah et al. Cureus 2019 May 11(5) e4790
• Using Machine Learning to Classify Individuals With Alcohol Use Disorder Based on Treatment Seeking Status.
  Lee Mary R et al. EClinicalMedicine 2019 Jul 1270-78
• The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.
  Kayson Elise et al. Journal of Huntington's disease 2019 Jul
• UnitedHealthcare To Cover Genetic Testing for Precision Medicine in Depression, Anxiety
  Clinical Omics, August 2, 2019

more